Harmony Biosciences shareholders elect four directors, ratify auditor, approve say-on-pay at 2026 annual meeting

Harmony Biosciences Holdings, Inc.

All four Class III director nominees elected: Geno Germano (44.96M for), Troy Ignelzi (32.81M), Ron Philip (31.83M), Andreas Wicki (25.11M).
Deloitte & Touche ratified as independent auditor for FY2026 with 49.39M for, 0.83M against, 0.17M abstain.
Say-on-pay advisory vote approved: 33.25M for, 13.04M against, 0.19M abstain; broker non-votes of 3.89M.
Quorum of 50.38M shares represented out of outstanding; all proposals passed.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.